| Literature DB >> 34354364 |
Baoliang Zhang1,2,3, Guanghui Chen1,2,3, Xi Chen1,2,3, Xiaoxi Yang1,2,3, Tianqi Fan1,2,3, Chuiguo Sun1,2,3, Zhongqiang Chen1,2,3.
Abstract
PURPOSE: Ossification of the ligamentum flavum (OLF) is a multifactorial disease characterized by an insidious and debilitating process of abnormal bone formation in ligamentum tissues. However, its definite pathogenesis has not been fully elucidated. Potential links between the immune system and various forms of heterotopic ossification have been discussed for many years, whereas no research investigated the immune effects on the initiation and development of OLF. Therefore, we attempt to shed light on this issue.Entities:
Keywords: bioinformatics; differentially expressed genes; immune infiltration; lncRNAs; ossification of ligamentum flavum
Year: 2021 PMID: 34354364 PMCID: PMC8331123 DOI: 10.2147/JIR.S318009
Source DB: PubMed Journal: J Inflamm Res ISSN: 1178-7031
Figure 1The overview of the analysis procedure.
Basic Clinical Data of Included Patients from OLF Group and Normal Group
| OLF Group | Normal Group | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Patient Number | Diagnosis (Location) | Gender | Age (Years) | BMI (kg/m2) | Patient Number | Diagnosis (Location) | Gender | Age (Years) | BMI (kg/m2) |
| 1 | TOLF (T10–11) | Male | 53 | 23.88 | 1 | TDH (T11–12) | Female | 65 | 26.35 |
| 2 | TOLF (T11–12) | Male | 64 | 26.87 | 2 | TF (T6–9) | Male | 70 | 29.41 |
| 3 | TOLF (T10–12) | Female | 60 | 28.52 | 3 | TDH (T10–12) | Male | 62 | 31.70 |
| 4 | TOLF (T11–12) | Male | 73 | 24.77 | 4 | TF (T12) | Male | 48 | 19.53 |
| 5 | TOLF (T8–12) | Male | 62 | 23.88 | 5 | TDH (T10–12) | Male | 76 | 25.97 |
| 6 | TOLF (T1–3, T6–9) | Male | 63 | 31.02 | 6 | TDH (T9–11) | Male | 53 | 28.41 |
| 7 | TOLF (T1–5) | Female | 53 | 25.25 | 7 | TDH (T11–12) | Female | 61 | 30.44 |
| 8 | TOLF (T10–12) | Male | 64 | 33.67 | 8 | TF (T10, T12) | Male | 54 | 24.49 |
| 9 | TOLF (T11–12) | Male | 60 | 32.04 | 9 | TDH (T11–L1) | Female | 58 | 29.30 |
| 10 | TOLF (T8–10) | Female | 53 | 27.70 | 10 | TDH (T8–10) | Male | 61 | 25.26 |
Abbreviations: TOLF, thoracic ossification of ligamentum flavum; TDH, thoracic disc herniation; TF, thoracic fracture; BMI, body mass index.
Figure 2The comparison of immune score and macrophage score between normal samples and OLF samples based on ssGSEA algorithm. (A) Immune score. (B) Macrophage score.
Figure 3The landscape of immune infiltration between OLF and normal tissues. (A) PCA cluster visualizing 64 types of differentially infiltrated immune cells based on xCell algorithm. (B) PCA visualizing 23 types of differentially infiltrated immune cells based on ssGSEA algorithm. (C) Heatmap of 23 infiltrating immune cells between normal and OLF tissues. (D) Heatmap of 64 infiltrating immune cells between normal and OLF tissues.
Figure 4The situation of differential immune infiltration between normal and OLF samples. (A) The relative percentage of 14 differential immune cells between normal and OLF samples. Horizontal axes represents 4 × normal samples and 4 × OLF samples, and vertical axes represents the percentage of different immune cells in each sample. Color bars on right of the map represent immune cell types. (B) Radar chart depicting 14 types of infiltrating immune cells with different proportions. *, ** and *** indicate the significance level of 0.05, 0.01 and 0.001, respectively. (C) Correlation heatmap of 14 differential immune cells.
Figure 5Up-regulated infiltrating immune cells in OLF. Red represents the expression of immune cells in normal LF tissues, and blue represents the expression of immune cells in OLF tissues. (A) Basophils. (B) B-cells. (C) cDC. (D) CMP. (E) Memory B-cells. (F) MSC. (G) pDC. (H) Pro-B cells.
Figure 6Down-regulated infiltrating immune cells in OLF. Red represents the expression of immune cells in normal LF tissues, and blue represents the expression of immune cells in OLF tissues. (A) Macrophages M2. (B) NKT. (C) Preadipocytes. (D) Smooth muscle cells. (E) NK CD56bright cells. (F) Th1 cells.
Figure 7Differentially expressed genes and lncRNAs between OLF samples and normal samples. (A) Volcano plot of differentially expressed genes. (B) Volcano plot of differentially expressed lncRNAs. (C) Heatmap of differentially expressed genes. (D) Heatmap of differentially expressed lncRNAs. Green dots indicates down-regulated, red indicates up-regulated and gray indicates no differential expression.
Figure 8Immune-related differentially expressed genes and lncRNAs between OLF samples and normal samples. (A) Venn diagram showing the overlapping between immune-related genes and OLF-related differentially expressed genes. (B) Heatmap of 14 OLF-related and immune-related differentially expressed genes (OIDEGs). (C) Box plot showing expression level of 14 OIDEGs between normal and OLF samples. (D) Correlation heat map of 14 OIDEGs. (E) Heatmap of 46 OIDEGs-related differentially expressed lncRNAs.
Detailed Information on 14 Hub OIDEGs
| Gene Symbols | Full Names | Gene Function | P value | Regulation |
|---|---|---|---|---|
| CD1E | CD1e Molecule | It is a T-cell surface glycoprotein that soluble binds diacetylated lipids | 3.46E-04 | Up |
| STAT3 | Signal Transducer And Activator Of Transcription 3 | Mediates the expression of a variety of genes in response to cell stimuli, and thus plays a key role in many cellular processes such as cell growth and apoptosis | 3.89E-04 | Down |
| CRH | Corticotropin Releasing Hormone | A major regulator of homeostasis, mediating the autonomic, behavioral and neuroendocrine responses to stress and also play a role in cell growth and survival | 6.20E-04 | Up |
| FAM3B | FAM3 Metabolism Regulating Signaling Molecule B | Induces apoptosis of alpha and beta cells in a dose- and time-dependent manner | 6.22E-04 | Down |
| GRP | Gastrin Releasing Peptide | Regulates numerous functions of the gastrointestinal and central nervous systems, including release of gastrointestinal hormones, smooth muscle cell contraction, and epithelial cell proliferation | 7.70E-04 | Up |
| SOCS3 | Suppressor of Cytokine Signaling 3 | Cytokine-inducible negative regulators of cytokine signaling and the expression of this gene is induced by various cytokines, including IL6, IL10, and interferon (IFN)-gamma | 1.80E-03 | Down |
| IFNB1 | Interferon Beta 1 | The type I class of interferons involved in cell differentiation, antiviral, antibacterial, anticancer activities, inducing transcription of genes encoding inflammatory cytokines and chemokines. | 2.37E-03 | Up |
| CCL28 | C-C Motif Chemokine Ligand 28 | Chemotactic activity for resting CD4, CD8 T-cells and eosinophils and binds to CCR3 and CCR10 and induces calcium mobilization in a dose-dependent manner. | 2.64E-03 | Up |
| CD40LG | CD40 Ligand | Acts as a ligand for CD40 receptor for activation of CD40-CD40LG signaling, which have cell-type dependent effects, such as B-cell activation, NF-kappa-B signaling and anti-apoptotic signaling | 3.86E-03 | Up |
| GDF15 | Growth Differentiation Factor 15 | Regulates food intake, energy expenditure and body weight in response to metabolic and toxin-induced stresses | 6.18E-03 | Down |
| MUC4 | Mucin 4 | Alter cellular behavior through both anti-adhesive effects on cell-cell and cell-extracellular matrix interactions and in its ability to act as an intramembrane ligand for ERBB2 | 8.05E-03 | Up |
| LGR5 | Leucine Rich Repeat Containing G Protein-Coupled Receptor 5 | Potentiates the canonical Wnt signaling pathway and acts as a stem cell marker of the intestinal epithelium and the hair follicle | 1.06E-02 | Down |
| IKBKE | Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Epsilon | Plays an essential role in regulating inflammatory responses to viral infection, through the activation of the type I IFN, NF-kappa-B and STAT signaling | 1.80E-02 | Down |
| TACR1 | Tachykinin Receptor 1 | It is a receptor for the tachykinin neuropeptide substance P. | 1.93E-02 | Down |
Abbreviation: OIDEGs, OLF-related and immune-related differentially expressed genes.
OIDEGs-Related Differentially Expressed LncRNAs Between OLF and Normal Groups
| OIDEG-Related DELs | Names | Number |
|---|---|---|
| Up-regulated | AC106779.1, NPRL3, CR383656.10, ZMAT4, NUP210P1, AC079089.1, FO393414.3, AC079943.2, MED21, LINC01137, RHOXF1P1, AC022816.1, SILC1, LINC01227, AC015983.2, PTPRM, AC097522.2, DNAAF5, MON2, DLX6-AS1, ADAMTS3, LINC02662, AC007922.1, AC016717.2, TRIM61, AC007953.2, SLC22A2, RFPL3S, LINC01700, AC188617.2, SLC22A16, POLR3A, AL365181.1, ZNF195, AL589987.2, AFAP1L2 | 36 |
| Down-regulated | BMS1P10, HOPX, SORD2P, ARHGAP22, GAS2L1P2, LINC00601, AC096734.1, AL356495.1, LINC00682, LINC01558 | 10 |
Note: OIDEGs-related DELs were set as r > 0.9 and p value < 0.01.
Abbreviations: OIDEGs, OLF-related and immune-related differentially expressed genes; DELs, differentially expressed lncRNAs.
Figure 9Functional enrichment analysis of OIDEGs. (A) The top 20 GO terms with significantly differential expression from the GO enrichment analyses. (B) The most significant functions of hub enriched OIDEGs. (C) The top 20 KEGG pathways with significantly differential expression from KEGG enrichment analysis. (D) The most significant pathways of hub enriched OIDEGs.
Figure 10Correlation analysis between OIICs and OIDEGs. (A) Correlation coefficient matrix diagram between 14 OIICs and 14 OIDEGs. (B) STAT3-cDC correlation. (C) SOCS3-cDC correlation. (D) FAM3B-cDC correlation. (E) CD1E-cDC correlation. (F) CD40LG-cDC correlation. (G) STAT3-NK CD56 bright cells correlation. (H) LGR5-preadipocytes correlation. (I) IFNB1-smooth muscle cells correlation.
Figure 11Correlation analysis between OIDELs and OIDEGs. (A) Correlation heat map between 46 OIDELs and 14 OIDEGs. (B) SILC1-CD1E correlation. (C) ZMAT4-CD1E correlation. (D) BMS1P10-CD1E correlation. (E) DLX6-AS1-STAT3 correlation. (F) SILC1-STAT3 correlation. (G) PTPRM-GRP correlation. (H) DLX6-AS1-SOCS3 correlation. (I) DNAAF5-CRH correlation.
Figure 12Alluvial plot depicting predicted lncRNA-gene-immunocyte regulated network in OLF, including 10 OIDEGs, 41 OIDELs and 7 OIICs.
Figure 13Validation of the expression of 10 hub OIDEGs between OLF and normal controls by qRT-PCR. (A) CD1E. (B) STAT3. (C) CRH. (D) FAM3B. (E) GRP. (F) SOCS3. (G) IFNB1. (H) CD40LG. (I) MUC4. (J) LGR5. (K) Fold changes of the mean expression value of OIDEGs. Error bars represented mean ± standard deviation for each group. **P < 0.01, ***P < 0.001.